Suppr超能文献

相似文献

2
Progression, Remission and Regression of Chronic Renal Diseases.
Nephron. 2016;134(1):20-4. doi: 10.1159/000445844. Epub 2016 Apr 21.
4
Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration.
Nephrol Dial Transplant. 2015 May;30(5):706-12. doi: 10.1093/ndt/gfu261. Epub 2014 Aug 2.
6
Spectrum of renal disease in diabetes.
Nephrology (Carlton). 2014 Sep;19(9):528-36. doi: 10.1111/nep.12288.
7
Endothelin antagonists and renal protection.
J Cardiovasc Pharmacol. 2000;35(4 Suppl 2):S75-78. doi: 10.1097/00005344-200000002-00017.
8
Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies.
Diabetes Care. 2002 May;25(5):900-5. doi: 10.2337/diacare.25.5.900.
10
Obesity and chronic kidney disease.
Nefrologia. 2011;31(4):397-403. doi: 10.3265/Nefrologia.pre2011.May.10963. Epub 2011 May 30.

引用本文的文献

1
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort.
Clin Kidney J. 2025 Aug 13;18(9):sfaf258. doi: 10.1093/ckj/sfaf258. eCollection 2025 Sep.
2
Assessment of prevalence and risk factors of chronic kidney disease in A. Konduru tribal region of Andhra Pradesh, India: A cross-sectional study.
J Family Med Prim Care. 2025 Jul;14(7):2958-2965. doi: 10.4103/jfmpc.jfmpc_347_25. Epub 2025 Jul 21.
5
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications.
Clin Kidney J. 2024 Nov 27;18(1):sfae370. doi: 10.1093/ckj/sfae370. eCollection 2025 Jan.
6
Chronic Complications of Diabetes: Prevalence, Prevention, and Management.
J Clin Med. 2024 Nov 21;13(23):7001. doi: 10.3390/jcm13237001.
9
Fractional Excretion of Urate is Positively Associated with Type 2 Diabetes in HUA Patients: A Cross-Sectional Study.
Diabetes Metab Syndr Obes. 2024 Apr 13;17:1701-1713. doi: 10.2147/DMSO.S454711. eCollection 2024.
10
Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients.
Ren Fail. 2024 Dec;46(1):2296609. doi: 10.1080/0886022X.2023.2296609. Epub 2024 Jan 4.

本文引用的文献

2
The kidney, a cardiovascular risk marker, and a new target for therapy.
Kidney Int Suppl. 2005 Sep(98):S25-9. doi: 10.1111/j.1523-1755.2005.09805.x.
3
Cardiovascular risk in diabetic kidney disease: a model of chronic renal disease.
Kidney Int Suppl. 2005 Sep(98):S18-20. doi: 10.1111/j.1523-1755.2005.09803.x.
5
Apolipoprotein E and progression of chronic kidney disease.
JAMA. 2005 Jun 15;293(23):2892-9. doi: 10.1001/jama.293.23.2892.
6
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.
Kidney Int. 2005 Jul;68(1):206-16. doi: 10.1111/j.1523-1755.2005.00395.x.
7
New capillary growth: a contributor to regression of sclerosis?
Curr Opin Nephrol Hypertens. 2005 May;14(3):201-3. doi: 10.1097/01.mnh.0000165883.08675.ab.
8
Experience with a program for prevention of chronic renal failure in India.
Kidney Int Suppl. 2005 Apr(94):S75-8. doi: 10.1111/j.1523-1755.2005.09419.x.
9
Genetic factors in end-stage renal disease.
Kidney Int Suppl. 2005 Apr(94):S46-9. doi: 10.1111/j.1523-1755.2005.09411.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验